{"database":"ecrin-mdr-crc","file_versions":[],"scores":null,"additional":{"omics_type":["Clinical"],"study_start_year":["2010"],"condition":["Neoplasm Metastasis","Hepatic Metastases","Cancer-Bowel-Back passage (rectum) or large bowel (colon)","Colorectal Cancer","Colorectal Neoplasms","colorectal liver metastases","Cancer-Liver"],"disease":["Neoplasm Metastasis","Hepatic Metastases","Colorectal Cancer","Colorectal Neoplasms","Cancer-bowel-back Passage (rectum) Or Large Bowel (colon)","Colorectal Liver Metastases","Cancer-liver"],"study_type":["Interventional"],"full_dataset_link":["https://newmdr.ecrin.org/Study/2085285"],"location":["New Zealand","Germany"],"study_start_month":["3"],"keyword":["Resectable hepatic metastases of colorectal cancer"],"repository":["ECRIN MDR"],"study_status":["Not provided"],"additional_accession":[]},"is_claimable":false,"name":"Resection of Colorectal Liver Metastases With or Without Routine Hilar Lymphadenectomy","description":"It is uncertain, whether hilar lymphadenectomy should be performed routinely in patients undergoing resection of colorectal liver metastases.\nFor this reason it is the aim of the present prospective randomized trial to evaluate, if routine lymphadenectomy reduces recurrent disease in patients undergoing resection of colorectal liver metastases.","dates":{"creation":"2010-03-15"},"accession":"2085285","cross_references":{"ClinicalTrials___gov":["NCT01073358"],"Australian New Zealand Clinical Trials Registry":["ACTRN12614001195640"]}}